Form 4: GRI Bio Director Receives Stock Grant
Insider Transaction (Form 4)
David Leslie Szekeres, a Director of GRI Bio, Inc., received 6,558 shares of common stock on November 4, 2026.
Summary
- Grant/award: acquired 6,558 Stock Option (Right to Buy) on November 4, 2026; holds 6,558 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
David Leslie Szekeres — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-04 | Grant/award | Stock Option (Right to Buy) | 6,558 | — | — | 6,558 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-04 | Grant/award (6,558 shares) |
Keywords
insider transaction, Form 4, GRI, GRI Bio, Inc., neutral, David Leslie Szekeres
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.